301357-87-9
301357-87-9
Chemical Structure
BMD4503-2
- CAS No.: 301357-87-9
- Formula:C26H21N5O3S
- Molecular Weight:483.54
IUPAC Name: N-(4-(N-(3-(naphthalen-1-ylamino)quinoxalin-2-yl)sulfamoyl)phenyl)acetamide
InChIKey: NCZQTIRXSCXOKR-UHFFFAOYSA-N
SMILES: CC(NC1=CC=C(C=C1)S(=O)(NC2=NC3=CC=CC=C3N=C2NC4=C5C=CC=CC5=CC=C4)=O)=O
Biological Activity: BMD4503-2 is a quinoxaline derivative with inhibitory activity against LRP5/6-sclerostin interactions. BMD4503-2 restores the activity of the Wnt/β-catenin signaling pathway by competitively binding to the LRP5/6-sclerostin complex. BMD4503-2 can be used in the study of Wnt signaling pathways in bone development, maintenance and osteoporosis[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BMD4503-2 | 99.21% | BMD4503-2 is a quinoxaline derivative with inhibitory activity against LRP5/6-sclerostin interactions. BMD4503-2 restores the activity of the Wnt/β-catenin signaling pathway by competitively binding to the LRP5/6-sclerostin complex. BMD4503-2 can be used in the study of Wnt signaling pathways in bone development, maintenance and osteoporosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
